创伤性脑损伤与认知障碍老年退伍军人的血液生物标志物
研究纳入155名退伍军人,其中65名有TBI史,35名TBI合并认知障碍。检测CNS来源外泌体中的p-tau、NfL、IL-6、TNF-α等标志物,发现这些标志物组合可区分TBI有无认知障碍(AUC 0.85)及认知障碍有无TBI(AUC 0.88)。
要点
- TBI史者中65%为轻度TBI,距最近TBI平均37年。
- p-tau、NfL、IL-6、TNF-α与TBI合并认知障碍相关(p<0.05)。
- 联合标志物区分TBI有无认知障碍的AUC为0.85(95%CI 0.74-0.95)。
核心结论
- 血液CNS富集外泌体标志物水平升高与TBI和认知障碍相关,甚至在TBI后数十年仍可检测到。
研究设计与样本
- 从2家退伍军人退休之家纳入155名退伍军人:90名无TBI,65名有TBI史。
- 进一步分为对照组(无TBI无认知障碍,n=60)、无TBI有认知障碍(n=30)、有TBI无认知障碍(n=30)、有TBI有认知障碍(n=35)。
- TBI由俄亥俄州立大学TBI识别方法确定;认知障碍定义为认知测试受损、痴呆诊断或使用痴呆药物。
- 血液标本富集CNS来源外泌体,用超敏免疫分析法检测蛋白质和细胞因子。
主要发现
- 退伍军人平均年龄79岁;有TBI史者中65%为轻度TBI,距最近TBI平均37年。
- 校正分析中,TBI和认知障碍组在CNS富集外泌体p-tau、NfL、IL-6、TNF-α浓度上存在差异(均p<0.05),GFAP(p=0.06),Aβ42或其他标志物无差异。
- 校正AUC分析显示,所有显著相关标志物联合可区分有/无认知障碍的TBI(AUC 0.85;95%CI 0.74-0.95)。
- 联合标志物可区分有/无TBI的认知障碍(AUC 0.88;95%CI 0.77-0.99)。
关键数值与推荐
- TBI合并认知障碍与CNS富集外泌体p-tau、NfL、IL-6、TNF-α相关(均p<0.05)。
- 联合标志物区分TBI有无认知障碍的AUC为0.85(95%CI 0.74-0.95)。
- 联合标志物区分认知障碍有无TBI的AUC为0.88(95%CI 0.77-0.99)。
临床怎么用
- 对于有TBI史的老年退伍军人,可考虑检测CNS富集外泌体p-tau、NfL、IL-6、TNF-α以辅助评估认知障碍风险。
- 联合标志物可能有助于区分TBI后认知障碍,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether blood-based biomarkers can differentiate older veterans with and without traumatic brain injury (TBI) and cognitive impairment (CogI). METHODS: We enrolled 155 veterans from 2 veterans' retirement homes: 90 without TBI and 65 with TBI history. Participants were further separated into CogI groups: controls (no TBI, no CogI), n = 60; no TBI with CogI, n = 30; TBI without CogI, n = 30; and TBI with CogI, n = 35. TBI was determined by the Ohio State University TBI Identification Method. CogI was defined as impaired cognitive testing, dementia diagnosis, or use of dementia medication. Blood specimens were enriched for CNS-derived exosomes. Proteins (neurofilament light [NfL], total tau, glial fibrillary acidic protein [GFAP], α-synuclein, β-amyloid 42 [Aβ42], and phosphorylated tau [p-tau]) and cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6], and interleukin-10) were measured using ultrasensitive immunoassays. RESULTS: Veterans were, on average, 79 years old. In participants with TBI history, 65% had mild TBI; average time from most recent TBI was 37 years. In adjusted analyses, the TBI and CogI groups differed on CNS-enriched exosome concentration of p-tau, NfL, IL-6, TNF-α (all p < 0.05), and GFAP (p = 0.06), but not on Aβ42 or other markers. Adjusted area under the curve (AUC) analyses found that all significantly associated biomarkers combined separated TBI with/without CogI (AUC, 0.85; 95% confidence interval [CI], 0.74-0.95) and CogI with/without TBI (AUC, 0.88; 95% CI, 0.77-0.99). CONCLUSIONS: Increased levels of blood-based, CNS-enriched exosomal biomarkers associated with TBI and CogI can be detected even decades after TBI. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in veterans with a history of TBI, CNS-enriched exosome concentration of p-tau, NfL, IL-6, and TNF-α are associated with CogI.
引用
- Peltz CB, Kenney K, Gill J, et al. Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans. Neurology. 2020. PMID: 32571850. doi:10.1212/WNL.0000000000010087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。